Diasonics has begun shipments of its 2-D array probes followingclearance of the transducers last month by the Food and Drug Administration.The family consists of three probes, in 12-MHz, 7-MHz, and 6-MHzfrequencies, all of which use Diasonics' matched
Diasonics has begun shipments of its 2-D array probes followingclearance of the transducers last month by the Food and Drug Administration.The family consists of three probes, in 12-MHz, 7-MHz, and 6-MHzfrequencies, all of which use Diasonics' matched impedance technology,according to Kenneth Marich, director of marketing communicationsfor the Santa Clara, CA, company.
The 12-MHz probe is a flat linear array for small parts applications,the 7-MHz is a flat linear array for vascular applications, andthe 6-MHz is a curved array for neonatal use, Marich said. Allare available for use on Diasonics Gateway scanners. Diasonicsbelieves that 2-D arrays offer improved spatial and contrast resolution.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.